• Haji Muhammad Aslam Channa
  • Muhammad Ashfaq
  • Shah Murad Mastoi
  • Muhammad Azam Qureshi


Background: Administration of quinolone therapy is controversial during growing age as statedby earlier worker. The flroquinolones are currently not indicated for young children, because ofarthropathy and adverse effect on growing cartilage shown by studies. However the effects ofciprofloxacin on epiphyseal growth plate has remained undocumented. This study is therefore,undertaken to determine the risk of ciprofloxacin administration an growing cartilage byprospective experimental animal study model using Wistar albino rat pups. Methods:Ciprofloxacin was administered to newly born Wistar albino rat pups with a doze of 20mg/kgbody weight intraperitonealy twice a day from day-1 to day-14 after birth. The animals weresacrificed by deep ether anesthesia. The limbs were disarticulated from axial skeleton, soft tissuewas removed. The intact bone mean length in millimeter of right and left humerus and femur wasmeasured with the help of electronic vernier caliper and bones were fixed in 10% bufferedfarmalin. Decalcification was done in 10% nitric acid and 10% formic acid changes. Afterparaplast embeding, 4 mm thick longitudinal sections of the proximal long bones were cut by arotary microtome. Routine staining with haemotoxylin and eosin was performed.Histomorphometry was done measuring the thickness of epiphyseal cartilage and was comparedwith similar value of control animals. The results were statistically analysed to find out thesignificance. Results: The ciprofloxacin induces a mordanting effect as abviated by increasedbasophilia. Our study reveales that cirprofloxacin administration in the newly born pups decreasedthe width of epiphyseal growth plate cartilage by 10.43% in humerus and 4.72% in femur ascompared to the growth of control cartilage. The decrease in the width was brought about mainlyby the reduced count of the proliferative cells in the proliferative zone and the diminuation in theaverage size of the hypertrophic condryocytes in the hypertrophic zone. The reserve zone hasbecome markedly reduced in thickness. Conclusion: The ciprofloxacin post-natal administrationeffected growth plate retardation by inhibiting the mitosis in the proliferative zone and alsoeffected the mean length of humora & femora leading to reduction in limb length of rat pups.Key words: Ciprofloxacin – Cartilage Toxicity- Cartilage growth – Bone Ossification – Growthrate – Epiphyseal plate – Chondrocyte.


Patterson, Reid D, Illinois, Park A. Quinolone Toxicity –

Methods of Assessment. Am J Med, 1991, 91 (Supl 6A):

S- 37S.

Patterson, Lance R, Lissack LM, Canter K, Asching CE,

Counie C, et al. Therapy of Lower Extremity Infections with

Ciprofloxacin in Patient with Diabetes Mellitus, Peripheral

Vascular Disease or both. Am J Med, 1989; 86: 801 – 808.

Katzung BG. Quinolones. In: Basic and Clinical

Pharmacology. 8th Ed. New York: Mc Graw Hill, 2001: 797 –

Gillman GA, Hardman JG, Limbird LE. The Quinolones. In:

Goodman & gillman’s. The Pharmacological Basis of

Therapeuctics. 10th ed. New York: Mc Graw Hill, 2001 Vol.

II: 1179 – 1183.

Grassmick BK, Lehr VT, Sundareson AS. Fulminanat

hepatic failure possibly related to Ciprfloxacin. Ann

Pharmacother, 1992, 26: 636 – 639.

Simpson J, Wasten AR, Mellersh A, Nelson CS, Dodd K.

Typhoid Fever, Ciprofloxacin and Renal Failure. Arch disc

Child, 1991, 66: 1083– 1084.

Greenberg RN, Kennedy DJ, Reilly PM, Luppen KL.

Treatment of Bones Joint and Soft Tissue Infection with oral

Ciprofloxacin. Antiomicrob Agent Chemother, 1987; 31: 151

– 155.

Lewinson D, Harel Z, Shenzer P,Sibermann M, Hochberg Z.

Effect of thyroid harmone and growth harmone on recovery

from hypotheroidism of epiphyseal growth plate cartilage and

its adjacent bone. Endocrinology, 1989, 124: 937-945.

Hooper DC,Wolfson JS, Swartz MN. Mechanism of Action

and Resistance to Ciprofloxacin. Am J Med; 1987; 82(S4):

– 20.

Schascht P, Arcieri G, Branolte J. World wide Clinical Data

on Efficacy and Safety of Ciprofloxacin. Infection; 1988;

(1): S29 – S43.

Arora NK. Are Fluoroquinolones safe in children?. India J

Pediatr. 1994; 61(6): 601-603.

Rough R. Reproductive System In: The Mouse. 2 nd ed.

Mineapolis: Burgress Pub Co, 1968: 269 – 299.

Chang HH, Schwartz Z, Kaufman MH. Limb & other Post

Cranial Skeletal Defects induced by Amniotic sac puncture in

mouse. J Anat, 1996; 189: 37 – 49.

Greene EC. Anatomy of Rat. Philadelphia: American

Philosphical Society, 1968; Vol. XXVIII, 5 – 30.

Martindale W. The Complete Drug Reference. 33rd ed.

Sweetman SC (Ed) London, Chicago: Pharmaceutical Press,

: 182 –185.

Lori EK, Suilk KK. Experimental Foetal Alchohol Syndrome

proposed pathogenic basis for a variety of associated facial

and brain anamalies. Am J Gen Med, 1992; 44: 168 – 176.

Bancroft JD, Stevens A. Theory and Practice of Histological

Technique. 3rd ed. Edinburgh: Churchill Livingston, 1990:

, 112, 323, 503.

Bland M. Introduction of medical statistics. 1st ed. Oxford:

Oxford University Press, 1987, 165 – 187.

Hooper DC. Mechanism of action of Antimicrobials: focus

on fluroquinolones. Clin Infect Dis, 2001, 32 Supl: S9 – S15.

Hooper DC. Mechanism of action and resistance of older and

newer fluroquinolones. Clin Infect Dis, 2000, 31 Suppl 2:

S24 – S28.

Piddock LJ. Mechanism of Fluoroquinolones Resistance an

uptdate 1994 – 1998. Drugs, 1998, 58 Suppl 2: 6– 10.

Hooper DC. Mode of action of fluoroquinolones. Drugs;

, 58 Suppl 2:6 – 10.

Stahlmann R, Lode H. Toxicity of Quinolones. Drugs; 1999,

Supl 2: 37-42.

Stahlmann R. Children as Special Population on Risk –

Quinolones as example for xenobiotics exhibiting skeletal

toxicity. Arch toxicol, 2003, 77(1): 7 – 11.

Young B, Health J.W. Skeletal tissues. In: Wheater’s

functionl Histology. 4th ed. Edinburgh: Churchill, New York,

Livingstone, 2000: 172-192

Most read articles by the same author(s)

1 2 > >>